Comparison of a TauroLock™ Based Regimen to 4% Citrate as Lock Solution in Tunneled Haemodialysis Catheters for the Prevention of Bacteraemia and Dysfunction
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 106 participants.
Also called NCT02789501
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 106 participants
- Sponsor
- Registry
-
NCT02789501
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- Not reported
- Countries
- Austria
- Registry status
- Completed
Technical summary
Registry record NCT02789501. Randomized; single masking; primary purpose prevention. Start 2012-01 (registry gives no type); primary completion 2016-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of a TauroLock™ Based Regimen to 4% Citrate as Lock Solution in Tunneled Haemodialysis Catheters for the Prevention of Bacteraemia and Dysfunction
- Condition
- Catheter Infections
- Condition
- End-stage Renal Disease
- Intervention (Device)
- 4% citrate lock solution regimen
- Intervention (Device)
- TauroLock lock solution regimen
- Lead sponsor
- Medical University of Vienna
Record details
- Record id
cardio:ct-nct02789501- Content hash
15aa16d1ed1da637ca4b47290cd18ed55b7552b679833e1375420cc96f35e139